S-337395
2402T1432
Phase 2 small_molecule active
Quick answer
S-337395 for Respiratory Syncytial Virus Infections is a Phase 2 program (small_molecule) at Shionogi B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shionogi B.V.
- Indication
- Respiratory Syncytial Virus Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active